Obesity Research & Clinical Practice

Obesity Research & Clinical Practice is the journal of the Asia Oceania Association for the Study of Obesity, published by Elsevier Ltd with copyright held by the association, founded in 2007 and centred on the epidemiology, mechanism, complications and treatment of obesity, with a 2025 Journal Impact Factor of 2.4 and a CiteScore of 4.0.《肥胖研究与临床实践》是亚太肥胖研究学会（Asia Oceania Association for the Study of Obesity）的会刊，由 Elsevier Ltd 出版、版权归该学会所有，2007 年创刊，内容以肥胖的流行病学、机制与治疗以及肥胖引发的并发症为中心，2025 年期刊影响因子为 2.4，CiteScore 为 4.0。

Scope

• The stated aim is to publish high quality clinical and basic research on the epidemiology, mechanism, complications and treatment of obesity, with the complications of obesity named as a subject in their own right.办刊宗旨是发表有关肥胖的流行病学、机制与治疗的临床与基础研究，并把肥胖的并发症单列为一项主题。
• Work from Asia and Oceania is particularly welcome, and the preference is explained by the rising burden of obesity across Asia Pacific, compounded by population-based and genetic features specific to the region.来自亚洲与大洋洲的研究尤其受欢迎，刊物给出的理由是亚太地区肥胖负担不断上升，叠加了该地区特有的人群与遗传特点。
• The readership it names runs from health care practitioners and clinical researchers to basic scientists, epidemiologists and public health officials, and the coverage is meant to reach all of them at once.刊物点明的读者从临床医生与临床研究者延伸到基础科学家、流行病学家与公共卫生官员，内容设计要同时抵达这几类人。
• Epidemiology is the first of the four subjects in the aims, so prevalence, incidence and risk factor work sits at the centre of the remit rather than at its edge.流行病学在宗旨的四个方向里排在首位，患病率与发病率以及危险因素研究因此处在中心位置。
• Mechanism covers the bench side of the brief, taking in work on how excess adiposity develops and on the pathways through which it acts on other organs.机制一侧覆盖实验台研究，既包括过剩脂肪如何形成，也包括它作用于其他器官的途径。
• Complications run through the content twice over, once as a clinical subject and once as the outcome that treatment is expected to prevent or postpone.并发症在内容里出现两重身份，一处是临床主题，一处是治疗要预防或延缓的结局。
• Treatment is the fourth subject, and the guide asks authors to report it against the relevant reporting standards, naming CONSORT and STROBE among them.治疗是第四个方向，投稿指南要求作者按相应的报告规范陈述，其中点名 CONSORT 与 STROBE。
• Practice in the title is carried by that readership claim, since the journal says it wants practitioners exposed to every area of obesity research rather than to one subfield.刊名里的「实践」由这一读者定位承载，刊物表示要让临床医生接触肥胖研究的各个方向，而不仅是一个分支。
• Reviews are a standing category, described as critical presentations of topics of interest to those active in prevention and treatment, generally invited but open to unsolicited work that is topical and of high quality.综述是常设栏目，定位为面向预防与治疗工作者的批判性梳理，一般按约稿处理，选题应时且质量高的自投稿也在考虑之列。
• Case reports are restricted to presentations that advance understanding of the pathophysiology or management of obesity and related syndromes, which keeps routine clinical description out of the category.病例报告只收能推进对肥胖及相关综合征病理生理或管理认识的稿件，常规的临床描述因此被挡在门外。
• Short communications and case reports share a ceiling of 1200 to 1500 words with three figures or tables and twenty references, a size that suits a single well defined finding.短篇通讯与病例报告同用 1200 至 1500 词的上限，图表 3 个、文献 20 篇，这个体量适合单一而明确的结果。
• Letters to the editor take responses to earlier articles and editorials, and the aims list comment on published papers among the things the journal exists to carry.致编辑的信承接对已发表文章与社论的回应，宗旨也把对已刊论文的评论列为刊物承担的内容之一。
• The proceedings and abstracts of the AOASO annual meeting appear as a supplement each year, which gives the journal a fixed slot for the conference output of the region.亚太肥胖研究学会年会的论文集与摘要每年以增刊形式出版，刊物因此在固定位置收录本地区的会议产出。
• Four societies stand behind the title, AOASO together with the Australian and New Zealand Obesity Society, the Taiwan Medical Association for the Study of Obesity and the Korean Society for the Study of Obesity.刊名背后有四家学会，除亚太肥胖研究学会之外还有澳新肥胖学会（ANZOS）、台湾肥胖医学会（TMASO）与韩国肥胖学会（KSSO）。
• Members of TMASO and KSSO read the journal online through their membership, while other readers reach it by separate subscription.台湾肥胖医学会与韩国肥胖学会的会员凭会籍可在线阅读该刊，其他读者则通过单独订阅获取。

History

• Volume 1 carries 2007, and the Europe PMC record agrees, since the earliest items filed under the print ISSN sit in volume 1, issue 1 of that year.第 1 卷标注 2007 年，Europe PMC 的记录与此一致，按纸本 ISSN 归档的最早条目正落在该年的第 1 卷第 1 期。
• One volume has covered one calendar year ever since, so volume 19 ran through 2025 and volume 20 through 2026.此后每年一卷，第 19 卷对应 2025 年，第 20 卷对应 2026 年。
• Six issues make up a volume, and the labels on current issues read in bimonthly pairs, September–October 2026 among them.每卷 6 期，现行各期的标注按双月成对出现，2026 年 9 月至 10 月号即是其中一例。
• The imprint has stayed with Elsevier Ltd, while the copyright line names the Asia Oceania Association for the Study of Obesity as owner rather than the publisher.出版方始终是 Elsevier Ltd，版权行则把所有者写为亚太肥胖研究学会。
• MEDLINE took the journal from the first volume, and a search of the print ISSN on Europe PMC returns 1368 records tagged with the MED source, the oldest dated 2007.MEDLINE 自第 1 卷起收录该刊，在 Europe PMC 检索纸本 ISSN 可得 1368 条记录，来源标记为 MED，最早的一条出自 2007 年。
• Scopus and the Science Citation Index Expanded are both listed today, and the aims page keeps an older form of the same claim naming PubMed, MEDLINE, Thomson Reuters and Scopus.目前列出的收录库包括 Scopus 与 Science Citation Index Expanded，宗旨页仍保留同一说法的旧版表述，其中点名 PubMed 与 MEDLINE 以及 Thomson Reuters 和 Scopus。
• Journal Citation Reports files it in two categories and gives it a Q3 place in each, 135 of 198 in endocrinology and metabolism and 73 of 114 in nutrition and dietetics.期刊引证报告把它归入两个类目，两处的四分位都是 Q3，内分泌与代谢类目在 198 种刊物中排第 135，营养与饮食类目在 114 种中排第 73。
• The 2025 Journal Impact Factor is 2.4, the five-year figure is 3.0, and Scopus puts the CiteScore at 4.0.2025 年期刊影响因子为 2.4，五年影响因子为 3.0，Scopus 给出的 CiteScore 为 4.0。
• Publisher statistics on the same page time a first decision at 8 days, a decision after review at 86 days, acceptance at 158 days and online publication 8 days after that.同一页的出版统计显示，首次决定需 8 天，外审后决定需 86 天，录用需 158 天，录用后 8 天在线发表。
• Output runs at about 77 articles a year, total citations reach 2363, and the cited half-life is 6 years.年发文约 77 篇，总被引 2363 次，被引半衰期为 6 年。
• Gold open access accounts for 32.2 per cent of the content by the publisher's count, which makes the title hybrid, with a subscription route alongside.按出版社统计，金色开放获取占全部内容的 32.2%，刊物因此走混合路线，订阅渠道与开放获取并行。
• Themed collections have appeared at intervals, one on genetic factors and metabolic pathways in early 2018 and a review collection on contemporary issues in obesity science in late 2017.主题专辑隔期推出，2018 年初有一期讨论影响肥胖发病的遗传因素与代谢通路，2017 年末有一期肥胖科学当代议题的综述专辑。
• The site also marks Editor's choice articles, two of the visible ones dated November 2019 and September 2024.刊站另有「Editor's choice」标记，可见的两篇分别标于 2019 年 11 月与 2024 年 9 月。

Editors

• Leonie Heilbronn of The University of Adelaide in Australia is one of the two editors-in-chief, and the pair spans the two ends of the journal's region.主编之一为（Leonie Heilbronn），任职于澳大利亚的 The University of Adelaide，两位主编分处该刊区域的两端。
• Kuo-Chin Huang of National Taiwan University holds the other post, which puts a Taiwanese institution at the head of a title that TMASO also backs.另一位主编为（Kuo-Chin Huang），任职于 National Taiwan University，台湾的机构由此进入一份同时得到台湾肥胖医学会支持的刊物的决策层。
• Gary Wittert, also at The University of Adelaide, is recorded as the previous editor-in-chief.前任主编为（Gary Wittert），同样任职于 The University of Adelaide。
• The board page reports 7 editors and editorial board members in 3 countries or regions, with Australia supplying 5, Korea 1 and Taiwan 1.编委页给出的人数是 7 位编辑与编委，分布在 3 个国家或地区，其中澳大利亚 5 位，韩国 1 位，台湾 1 位。
• Five associate editors handle manuscripts, four of them based in Australia and the fifth in Korea.5 位副编辑承担稿件处理，其中 4 位在澳大利亚，第 5 位在韩国。
• Samantha L. Hocking works at The University of Sydney Central Clinical School within the Charles Perkins Centre, and Yanchuan Shi at the Victor Chang Cardiac Research Institute.（Samantha L. Hocking）任职于 The University of Sydney Central Clinical School，属 Charles Perkins Centre；（Yanchuan Shi）在 Victor Chang Cardiac Research Institute。
• The single Korean affiliation on the list is Inje University Ilsan Paik Hospital, where Yeong Sook Yoon holds a post in the Department of Family Medicine.名单上唯一的韩国机构是 Inje University Ilsan Paik Hospital，（Yeong Sook Yoon）在该院家庭医学系任职。
• Lijun Zhao comes from Flinders University and Miaobing Zheng from the School of Health Sciences at the University of New South Wales.（Lijun Zhao）来自 Flinders University，（Miaobing Zheng）来自 University of New South Wales 的健康科学学院。
• Review is double anonymized, so neither the author nor the referee learns the other's identity at any stage.评审采用双盲，作者与审稿人在任何阶段都不知道对方身份。
• Submissions are screened by the editors first, and those judged suitable normally go to at least two reviewers for an independent assessment of scientific quality.稿件先由编辑初评，被认为合适的通常送给至少 2 位审稿人做独立的科学质量评估。
• Only one appeal per submission is considered, and the decision that follows it is final.每篇稿件只受理一次申诉，申诉之后的决定为终局。
• Editors withdraw from papers they wrote, papers by family members or colleagues, and papers about products or services in which they have an interest, with review run independently of the editor's group.编辑回避自己撰写的稿件，也回避亲属或同事撰写以及涉及本人利益的产品或服务的稿件，这类稿件的评审由与该编辑及其课题组无关的人员主持。
• Guest editors of a special issue may send submissions to reviewers and recommend a decision, but the journal editor oversees the review and makes the final call on acceptance.特刊的客座编辑可以送审并建议决定，评审过程仍由本刊编辑监督，最终录用权也在本刊编辑手中。
• The guide asks for people first language in titles and text, putting the individual before the condition, and offers the disabled and the elderly as the forms to replace.指南要求在标题与正文中使用以人为本的语言，先写人再写状况，并点出「the disabled」与「the elderly」是应当替换的写法。
• Pilot studies that clear desk review are sent back with a request to resubmit as a Research Letter before they go out for review, a route that shortens the process for small studies.通过初筛的预试验稿件会被退回，要求改投为研究快报之后再送外审，这条路径缩短了小样本研究的流程。
• Manuscripts are handled through Editorial Manager at editorialmanager.com/ORCP.稿件经 editorialmanager.com/ORCP 的 Editorial Manager 系统提交。